Feedback / Questions
soquelitinib (CPI-818) - Corvus Pharma
https://markets.businessinsider.com/news/stocks/corvus-pharmaceuticals-presents-soquelitinib-phase-1-atopic-dermatitis-data-at-the-society-for-investigative-dermatology-sid-annual-meeting-1036155524
May 14, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next